JPRN-UMIN000005998已完成2 期
A Phase II study of capecitabine plus cisplatin (plus trastuzumab) for previously untreated advanced gastric cancer. - XP+trastuzumab for advanced gastric cancer
Department of Digestive surgery, Kawasaki Medical University0 个研究点目标入组 53 人开始时间: 2011年8月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Forbidden case to use capecitabine and/or cisplatin (2) Infection or inflammatory case (3) Severe heart disease (4) Severe complicated case such as ileus, interstitial pneumonia, uncontrolled DM, liver cirrhosis etc (5) a lot of ascites (6) many bone metastasis (7) brain metastasis (8) repeated gastrointestinal bleeding (9) severe psychological disease (10) complicated other active cancer (11) pregnant or intended to be pregnant (12) intend to make pregnant (13) others
研究者
相似试验
已完成
2 期
A Phase II study of capecitabine plus cisplatin (plustrastuzumab) for previously untreated advanced gastric cancer.untreated advanced gastric cancerJPRN-UMIN000006458Ehime University45
已完成
2 期
PhaseII trial of capecitabine plus cisplatin in patients with recurrent HER-2 negative gastric cancer during or after the adjuvant chemotherapy using S-1 (T-CORE1102)HER2 negative gastric cancerJPRN-UMIN000006804Tohoku Clinical Oncoogy, Research and Education Society(T-CORE)21
招募中
2 期
A PhaseII study of XP(capecitabine plus cisplatin) combination therapy for HER2 negative advanced/recurrent gastric cancerHER2 negative advanced/recurrent gastric cancerJPRN-UMIN000013669SGCSG:Shimane Gstroenterological Vancer Study Group36
已完成
2 期
A Phase II Study of Capecitabine plus Paclitaxel Combination Chemotherapy in Patients with Metastatic Breast CancerMetastatic Breast CancerJPRN-UMIN000000869KBCSG (Kinki Breast Cancer Study Group)42
已完成
不适用
A phase II study of capecitabin plus oxaliplatin therapy (XELOX) for inoperable/advanced gastric cancer resistant/intolerable to fluoro-pyrimidine, CDDP, Taxane or CPT-11 (OGSG1403)unresectable/advanced gastric cancerJPRN-UMIN000016256Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)12